A 48-Week Multi-Centre, Open-Label, Local Phase IV Study to Demonstrate the Efficacy and Safety of Adefovir Dipivoxil Tablets (10mg) in Chinese Subjects With Compensated Chronic Hepatitis B.
Phase of Trial: Phase IV
Latest Information Update: 06 May 2014
At a glance
- Drugs Adefovir (Primary) ; Adefovir dipivoxil (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 08 Apr 2009 Actual patient number (1470) added as reported by ClinicalTrials.gov.
- 27 Oct 2008 Actual start date changed from Oct 2006 to Dec 2006 as reported by ClinicalTrials.gov.
- 27 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.